Directory
>
Anand Mandaliya
Anand Mandaliya
Investment Banking Summer Analyst | LYNQQ Inc.
California, Yorba Linda, United States
Anand Mandaliya
Summary
Anand Mandaliya is a seasoned executive in the biotechnology sector, currently serving as the Head of US Gross-to-Net Transformation at Amgen. With a robust background in finance and investment banking, he has transitioned into the healthcare industry, leveraging his expertise in risk management and pricing strategies. Anand holds an MBA in Finance from Pepperdine University and a BS in Finance from the University of Florida. His career spans various roles at Amgen, where he has demonstrated leadership in value and access strategies, contributing significantly to the company's mission of improving health outcomes through innovative therapies. Anand's multifaceted experience encompasses both corporate and analytical roles, showcasing his adaptability and commitment to excellence. He is passionate about integrating advanced human genetics into healthcare solutions and is dedicated to driving transformation in the biotech landscape.
Anand Mandaliya
Work Experience
Executive Director, Business Performance at
Amgen
August 2024 - Present
Anand Mandaliya
Education
Tampa Preparatory School, High School
University of Florida, BS, Finance
Pepperdine Graziadio School of Business and Management, MBA, Finance
Frequently Asked Questions about Anand Mandaliya
What is Anand Mandaliya email address?
Anand Mandaliya's primary email address is ********@amgen.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Anand Mandaliya work for?
Anand Mandaliya is a Investment Banking Summer Analyst at LYNQQ Inc..
Where Anand Mandaliya graduated from?
Anand Mandaliya holds a degree in null from Tampa Preparatory School.
How can I directly contact Anand Mandaliya?
To contact Anand Mandaliya directly, you can use the email address ********@amgen.com. Complete contact information is available upon registration with Muraena.
Who is Anand Mandaliya?
Anand Mandaliya is a seasoned executive in the biotechnology sector, currently serving as the Head of US Gross-to-Net Transformation at Amgen. With a robust background in finance and investment banking, he has transitioned into the healthcare industry, leveraging his expertise in risk management and pricing strategies. Anand holds an MBA in Finance from Pepperdine University and a BS in Finance from the University of Florida. His career spans various roles at Amgen, where he has demonstrated leadership in value and access strategies, contributing significantly to the company's mission of improving health outcomes through innovative therapies. Anand's multifaceted experience encompasses both corporate and analytical roles, showcasing his adaptability and commitment to excellence. He is passionate about integrating advanced human genetics into healthcare solutions and is dedicated to driving transformation in the biotech landscape.
Anand`s contact details
********@amgen.com